Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for USD 4.1 billion in cash
HBM Healthcare Investments AG
/ Key word(s): Acquisition
Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for USD 4.1 billion in cash
03.06.2022 / 17:46
HBM Healthcare Investments today announces that its portfolio company...